Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 19861-19870 Newer>

The Motley Fool January 18, 2007 Tom Taulli	Avaya Calling on the Net Despite its deal for Ubiquity Software, the telecom equipment maker still faces intense competition. Investors, take note.
The Motley Fool January 18, 2007 Anders Bylund	The Ups and Downs of Blockbuster The video rental operator has taken its fair share of beatdowns recently, and yet some market agents have voted with their wallets in support of the company. So who's right, and who's wrong?
The Motley Fool January 18, 2007 Tom Taulli	JPMorgan Chase: Discounted at Retail JPMorgan had a strong quarter, but it was diluted by weakness in its retail business. Despite JPMorgan's diversified model, there is certainly risk for investors.
The Motley Fool January 18, 2007	It Ain't Easy Being Banco Popular: Fool by Numbers Puerto Rico's largest homegrown bank released fourth-quarter 2006 earnings: Income Statement Highlights... Ratio Checkup... Balance Sheet Highlights...
The Motley Fool January 18, 2007 Ryan Fuhrmann	You Are Now Free to Invest About the Country Southwest shares should be on any savvy investor's radar screen.
The Motley Fool January 17, 2007 Rich Duprey	Courier Caught in Traffic: Fool by Numbers The book publisher released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool January 17, 2007 Rich Duprey	Foolish Forecast: A Hard Landing for Ryland The homebuilder will report fourth-quarter 2006 financial results shortly. Ryland looks to be a conventional builder that will be under the weather until the industry rebuilds itself.
The Motley Fool January 17, 2007 Nathan Parmelee	Keep an Eye on Commerce Commerce Bank is swirling in uncertainty, but its prospects for continued deposit growth are worth investors' attention.
The Motley Fool January 17, 2007 Brian Lawler	Dendreon in the Fast Lane The FDA speeds up review of Dendreon's leading drug candidate. Investors, take note.
The Motley Fool January 17, 2007 Ryan Fuhrmann	A Wealth of Data From Northern Trust: Fool by Numbers The bank released fourth-quarter and year-end 2006 earnings: Income Statement Highlights... Ratio Checkup... Balance Sheet Highlights...
<Older 19861-19870 Newer> Return to current articles.